BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1379762)

  • 1. Immunosuppressive macrolides.
    Stütz A
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):22-5. PubMed ID: 1379762
    [No Abstract]   [Full Text] [Related]  

  • 2. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 4. Categorizing receptor-signaling pathways with FK 506 and rapamycin.
    Hultsch T; Hohman RJ
    Transplant Proc; 1991 Dec; 23(6):2961-3. PubMed ID: 1721328
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.
    Bierer BE
    Proc Assoc Am Physicians; 1995 Apr; 107(1):28-40. PubMed ID: 8630742
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunophilin-ligand complexes as probes of intracellular signaling pathways.
    Schreiber SL; Liu J; Albers MW; Karmacharya R; Koh E; Martin PK; Rosen MK; Standaert RF; Wandless TJ
    Transplant Proc; 1991 Dec; 23(6):2839-44. PubMed ID: 1721293
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes.
    Dumont FJ; Kastner C; Iacovone F; Fischer PA
    J Pharmacol Exp Ther; 1994 Jan; 268(1):32-41. PubMed ID: 7507994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506 and rapamycin: molecular probes of T-lymphocyte activation.
    Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ
    Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
    Morris RE
    Transplant Proc; 1991 Dec; 23(6):2722-4. PubMed ID: 1721257
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the immunosuppressive macrolides rapamycin and FK 506 in high responder rats presensitized to major histocompatibility complex antigens.
    Propper DJ; Woo J; Macleod AM; Catto GR; Thomson AW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):673-4. PubMed ID: 7679837
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of FKBP to PKCI-2.
    Albers MW; Liu J; Schreiber SL
    Nature; 1991 Jun; 351(6327):527. PubMed ID: 1710782
    [No Abstract]   [Full Text] [Related]  

  • 12. Purification of a 50- to 58-kDa immunophilin from human spleen and a Jurkat T-cell line capable of binding cyclosporine A, FK 506, and rapamycin.
    Donnelly JG; Soldin SJ
    Transplant Proc; 1991 Dec; 23(6):2886-9. PubMed ID: 1721305
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of action of rapamycin (Sirolimus, Rapamune).
    Molnar-Kimber KL
    Transplant Proc; 1996 Apr; 28(2):964-9. PubMed ID: 8623482
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin.
    Carlson RP; Sehgal SN; Lewis AJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S129. PubMed ID: 8324938
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line.
    Wang SC; Zeevi A; Jordan ML; Simmons RL; Tweardy DJ
    Transplant Proc; 1991 Dec; 23(6):2920-2. PubMed ID: 1721312
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
    Sharkey J; Butcher SP
    Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T and B lymphocyte proliferation by rapamycin.
    Kay JE; Kromwel L; Doe SE; Denyer M
    Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506.
    Nakajima H; Oka T
    Transplant Proc; 1996 Apr; 28(2):1052-5. PubMed ID: 8623224
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of rapamycin on hematopoiesis.
    Quesniaux VF; Wehrli S; Wioland C; Schuler W; Schreier MH
    Transplant Proc; 1994 Dec; 26(6):3135-40. PubMed ID: 7998093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.